The companies agreed to enhance access to technology from DASI, a leader in AI-driven predictive modeling and digital twin ...

Washington, D.C. – May 2, 2025 – New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a strategy of early intervention with ...

Transcatheter aortic valve implantation improves health status and quality of life in older patients with aortic stenosis, but adding dapagliflozin confers no further benefit, a study finds.

WASHINGTON, DC — New European registry data on transcatheter aortic-valve replacement (TAVR) in patients at lower surgical risk than those studied in the pivotal randomized trials offers the ...

A previous analysis in this trial showed that among patients with severe, symptomatic aortic stenosis who were at low surgical risk, the rate of the composite end point of death, stroke, or ...

Saint Alphonsus in Boise earned a three-star TAVR ranking from STS and ACC, placing it among the nation’s top heart programs ...

Researchers support limiting these surgeries to centers that do the most cases, though true high-volume hospitals remain rare ...

Please provide your email address to receive an email when new articles are posted on . Transcatheter aortic valve replacement for younger adults with severe aortic stenosis rose nearly ninefold from ...

Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic valve stenosis. With proven safety and efficacy, TAVR has become a standard therapeutic alternative to surgical ...

SAN FRANCISCO, CA—Conduction abnormalities like complete heart block (CHB) and left bundle branch block (LBBB) remain common in today’s TAVI patients, with some facing pacemaker implantation or even ...

Patients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing transcatheter aortic valve replacement (TAVR) were significantly less likely ...